Physical function impairment and frailty in middle-aged people living with human immunodeficiency virus in the REPRIEVE trial ancillary study PREPARE

Keyphrases

• Middle-aged 100%
• Ancillary 100%
• Functional Impairment 100%
• Frailty 100%
• Physical Function 100%
• People Living with Human Immunodeficiency Virus 100%
• REPRIEVE 100%
• Hypertension 28%
• Physical Inactivity 28%
• Risk of Death 14%
• Old Age 14%
• Aging 14%
• Black Race 14%
• Antiretroviral Therapy 14%
• Sectional Analysis 14%
• Targeted Intervention 14%
• BMI Index 14%
• Low-to-moderate 14%
• Adjusted Analysis 14%
• Fall Risk 14%
• Hospitalization Risk 14%
• Short Physical Performance Battery 14%
• Pre-frail 14%
• High Waist Circumference 14%
• Pre-frailty 14%
• Modifiable Factors 14%
• Accelerated Development 14%
• Physically Inactive 14%
• 95% Confidence Interval 14%
• Cardiovascular Risk Factors 14%
• CD4 Cell Count 14%

Medicine and Dentistry

• Middle Age 100%
• Body Mass Index 100%
• Human Immunodeficiency Virus 100%
• Frailty 100%
• Physical Inactivity 50%
• Hypertension 50%
• Cardiovascular Disease 25%
• Cross Sectional Study 25%
• T-Helper Cell 25%
• Antiretroviral Therapy 25%
• Physical Performance 25%
• Cell Count 25%

Nursing and Health Professions

• Human Immunodeficiency Virus 100%
• Frailty 100%
• Physical Function 100%
• Hypertension 28%
• Physical Inactivity 28%
• Confidence Interval 14%
• Waist Circumference 14%
• CD4 Lymphocyte Count 14%
• Cardiovascular Disease 14%
• Body Mass 14%
• Antiretroviral Therapy 14%